http://medicalxpress.com/ en-us Medical Xpress internet news portal provides the latest news on Health and Medicine. Researchers at the University of Southern California (USC) have discovered a trigger by which the Hepatitis C virus enters liver cells ─ shedding light on how this serious and potentially deadly virus can begin to damage the liver. http://medicalxpress.com/news/2012-12-clue-hepatitis-virus-liver.html Diseases, Conditions, Syndromes Wed, 12 Dec 2012 09:28:38 EST news274526909 Just 20 percent of people infected with the hepatitis C virus (HCV) begin the recommended treatment regimen and less than 5 percent go on to successfully overcome the virus, according to a new review in General Hospital Psychiatry. This is despite the availability of highly effective anti-viral drugs that clear hepatitis C virus in about 80 percent of patients participating in clinical trials. Major barriers to recommended care are substance abuse and depression in HCV patients. http://medicalxpress.com/news/2012-12-people-hepatitis-untreated-effective-drugs.html Diseases, Conditions, Syndromes Mon, 10 Dec 2012 08:40:01 EST news274349852 Incarcerated patients with chronic hepatitis C virus (HCV) infection are just as likely to respond to treatment for the disease as patients in the community, according to findings published in the October issue of Hepatology, a peer-reviewed journal of the American Association for the Study of Liver Diseases. The study from the University of Wisconsin School of Medicine and Public Health (SMPH) in Madison found that HCV patients in prison were just as likely to achieve a sustained viral response (SVR) as non-incarcerated patients. http://medicalxpress.com/news/2012-09-hepatitis-infection-prison-good-policy.html Diseases, Conditions, Syndromes Thu, 27 Sep 2012 13:40:49 EST news267972037 Italian researchers report that severe fibrosis increases the early atherosclerosis risk in patients with genotype 1 chronic hepatitis C virus (HCV) infection. A second study found that fatty liver disease also increases risk of developing atherosclerosis at an earlier period. Both studies appear in the May issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases. http://medicalxpress.com/news/2012-04-fibrosis-fatty-liver-disease-early.html Diseases, Conditions, Syndromes Tue, 24 Apr 2012 10:52:31 EST news254483544 A new classification for diagnosing fibrosis in patients with chronic hepatitis C virus (HCV) has shown to be as accurate as currently used algorithms, but required no further liver biopsy. The study appearing in the January issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases, details a method that synchronously combines two fibrosis tests, providing a non-invasive and more precise fibrosis diagnosis. http://medicalxpress.com/news/2012-01-fibrosis-classification-accuracy-diagnosis-hepatitis.html Diseases, Conditions, Syndromes Tue, 10 Jan 2012 14:41:24 EST news245428874 The University of Liverpool has launched an iphone app, HEP i-chart, that provides Hepatitis C (HCV) patients with quick and easy access to the latest information about drug interactions. http://medicalxpress.com/news/2011-11-university-iphone-app-hepatitis-treatment.html Diseases, Conditions, Syndromes Tue, 22 Nov 2011 11:13:50 EST news241182824 British researchers have identified specific resistance mutations for two classes of p7 inhibitor, which may explain their lack of effectiveness in clinical trials combined with current standard of care. Study results support the role of p7 inhibitor combinations as potential components of future HCV-specific therapies and are available in the July issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases. http://medicalxpress.com/news/2011-06-p7-protein-resistance-mutations-drug.html Diseases, Conditions, Syndromes Tue, 28 Jun 2011 10:41:00 EST news228476444